Factors associated with cognitive impairment in patients with parkinson disease: An urban study

Clinica Terapeutica

Volumn 162, Issue 1, 2011, Pages 23-29

  Rosdinom, R ^a   Fazli, A ^a   Nik Ruzyanei, N J ^a   Azlin, B ^a   Srijit, D ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Activities; Caregiver; Cognitive impairment; Mini mental state examination; Parkinson disease

Indexed keywords

ADULT; AGED; ARTICLE; CAREGIVER; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; EDUCATIONAL STATUS; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PREVALENCE; PSYCHOMETRY; SCORING SYSTEM;

ACTIVITIES OF DAILY LIVING; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CAREGIVERS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALAYSIA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; URBAN POPULATION;

EID: 79953305452     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Caap-Ahlgren M, Lannerheim L. Older Swedish women's experiences of living with symptoms related to Parkinson's disease. J Adv Nurs 2002; 39(1):87-95
2. Ellgring H, Seiler S, Perleth B, et al. Psychosocial aspects of Parkinson's disease. Neurol 1993; 43:S41-4
3. Martínez-MP, Frades Payo B. Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. The Group Centre for Study of Movement Disorders. J Neurol 1998; 245(1):S34-8
4. Aarsland D, Larsen JP, Karlsen K, et al. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999; 14(10):866-74
5. Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurol 2001; 56(6):730-6
6. Website: http://www.statistics.gov.my. Last accessed on 11.3.2010
7. Stewart DA. NICE guideline for Parkinson's disease. Age ageing 2007; 36(3):240-2
8. Biggins CA, Boyd JL, Harrop FM, et al. A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55(7):566-71
9. Mayeux R, Denaro J, Hemenegildo N, et al. A populationbased investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992; 49(5):492-7
10. Bayles KA, Tomoeda CK, Wood JA, et al. Change in cognitive function in idiopathic Parkinson disease. Arch Neurol 1996; 53(11):1140-6
11. Palazzini E, Soliveri P, Filippini G, et al. Progression of motor and cognitive impairment in Parkinson's disease. J Neurol 1995; 242(8):535-40
12. Salganik I, Korczyn A. Risk factors for dementia in Parkinson's disease. Arch Neurol 1990; 53:343-7
13. Levin BE, Katzen HL Early cognitive changes and nondementing behavioural abnormalities in Parkinson's disease. Behavioural Neurology of Movement Disorders. Weiner WJ, Lang AE. (Eds.). Advances in Neurology. New York, Raven Press 1995; 65:85-95
14. Mohr E, Mendis T, Grimes JD. Late cognitive changes in Parkinson's Disease with emphasis on dementia. In: Behavioural Neurology of Movement Disorders. Weiner WJ, Lang AE. (Editors). Advances in Neurology. New York: Raven Press. 1995; 65:97-113
15. Mc Rae A. Neurotransmitter and pharmacology of the basal ganglia. In: Jankovic J, Tolosa E. (Eds.). Parkinson's disease and movement disorder. Baltimore, Williams and Wilkins, 1998; 47-66
16. Portin R, Rinnie UK. Neuropsychological responses of Parkinsonian patients to long-term levadopa treatment. In: Rinne, UK, Klinger M., Stanum G. (Editors.). Parkinson's disease: Current progress, problems and management. Amsterdam, Elsevier 1980; 271-304
17. Lewis SJ, Dove A, Robbins TW, et al. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003: 23(15):6351-6
18. Goldman WP, Baty JD, Buckles VD, et al. Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia. Arch Neurol 1998;55(5):674-80
19. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17(5):427-42
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189-98
21. Hodges JR. Standardized mental test schedules: Their uses and abuses. Cognitive Assessment For Clinicians. 1st edition, Oxford Medical Publication. Chapter 6, 1994: 182-7
22. Beatty WW, Staton RD, Weir WS, et al. Cognitive disturbances in Parkinson's disease. J Geriatr Psychiatry Neurol 1989; 2(1):22-33
23. Roca RP, Klein LE, Kirby SM, et al. Recognition of dementia among medical patients. Arch Intern Med 1984; 144(1):73-5
24. Sheikh K, Smith DS, Meade TW, et al. Repeatability and validity of a modifi ed activity of daily living (ADL) index in studies of chronic disability. Int Rehabil Med 1979; 1(2):51-8
25. Roman GC, Zhang ZX. Ellenberg JH..The neuroepidemiology of Parkinson's disease. In Etiology of Parkinson's disease. Marcel Decker Inc, Chapter 8, 1995; 210-31
26. Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000; 54(8):1596-602
27. Pai MC, Chan SH. Education and cognitive decline in Parkinson's disease: a study of 102 patients. Acta Neurol Scand 2001; 103(4):243-7
28. Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993; 269(18):2386-91
29. Bird HR, Canino G, Stipec MR, et al. Use of the Mini-mental State Examination in a probability sample of a Hispanic population. J Nerv Ment Dis 1987; 175(12):731-7
30. Fillenbaum GG, Hughes DC, Heyman A, et al. Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. Psychol Med 1988; 18(3):719-26
31. Nazem S, Siderowf AD, Duda JE, et al. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc 2009; 57(2):304-8
32. Kulisevsky J. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging 2000; 16(5):365-79
33. Starkstein SE, Bolduc PL, Preziosi TJ, et al. Cognitive impairments in different stages of Parkinson's disease. J Neuropsych Clin Neurosci 1989; 1(3):243-8
34. Tröster AI, Stalp LD, Paolo AM, et al. Neuropsychological impairment in Parkinson's disease with and without depression. Acta Neurol 1995; 52(12):1164-9
35. Marder K, Tang MX, Cote L, et al. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995; 52(7):695-701
36. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40(9):922-35
37. Faison KJ, Faria SH, Fank D. Caregivers of chronically ill elderly: perceived burden. J Commun Health Nursing 1999; 16(4):243-53